Evidence map›Paper›PMID 34349292›Full record

ReviewNature2021

The role of retrotransposable elements in ageing and age-associated diseases.

Vera Gorbunova, Andrei Seluanov, Paolo Mita, Wilson McKerrow, David Fenyö, Jef D Boeke, Sara B Linker, Fred H Gage, Jill A Kreiling, Anna P Petrashen and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 251 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
251citing papers in PubMed, 1 pooled it
58.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

251 citing papers in PubMed, 1 synthesis or guideline pooled it, 420 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. The Hallmarks of Aging: From Molecular Mechanisms to Clinical Translation.International journal of molecular sciences · 2026
    Review
  8. AcutebioRxiv : the preprint server for biology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

191 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Vera GorbunovaDepartment of Biology, University of Rochester, Rochester, NY, USA.ORCID http://orcid.org/0000-0001-8979-0333
Andrei SeluanovDepartment of Biology, University of Rochester, Rochester, NY, USA.ORCID http://orcid.org/0000-0003-3400-538X
Paolo MitaInstitute for Systems Genetics, NYU Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0002-2093-4906
Wilson McKerrowInstitute for Systems Genetics, NYU Langone Health, New York, NY, USA.
David FenyöInstitute for Systems Genetics, NYU Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0001-5049-3825
Jef D BoekeInstitute for Systems Genetics, NYU Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0001-5322-4946
Sara B LinkerLaboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-6653-1715
Fred H GageLaboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-0938-4106
Jill A KreilingCenter on the Biology of Aging, Brown University, Providence, RI, USA.
Anna P PetrashenCenter on the Biology of Aging, Brown University, Providence, RI, USA.
Trenton A WoodhamCenter on the Biology of Aging, Brown University, Providence, RI, USA.
Jackson R TaylorCenter on the Biology of Aging, Brown University, Providence, RI, USA.
Stephen L HelfandCenter on the Biology of Aging, Brown University, Providence, RI, USA.
John M SedivyCenter on the Biology of Aging, Brown University, Providence, RI, USA. john_sedivy@brown.edu.ORCID http://orcid.org/0000-0001-9363-4253
Brown University · USInstitute for Systems Biology · USSalk Institute for Biological Studies · USUniversity of Rochester · USJohn Brown University · US

Funding

Viral Vector Core (VVC)P30CA014195 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI Reuben Shaw · 1985 to 2026
$82.8M
The role of hyaluronan in longevity and cancer resistance of longest-lived rodentP01AG047200 · NIA · UNIVERSITY OF ROCHESTER · PI Vadim N. Gladyshev · 2014 to 2026
$36.9M
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?P01AG051449 · NIA · BROWN UNIVERSITY · PI John M Sedivy · 2016 to 2026
$30.4M
Stem Cells and AgingP20GM119943 · NIGMS · RHODE ISLAND HOSPITAL · PI QUESENBERRY, PETER J. · 2017 to 2021
$10.6M
Combinatorial Actions of Genetic Variants and Gender Bias of Alzherimer's DiseaseR01AG057706 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GAGE, FRED H, GLASS, CHRISTOPHER K · 2017 to 2021
$8.1M
The role of SIRT6 posttranslational modifications in aging and genome stability. Supplement: Testing SIRT6 activators as potential Alzheimer's disease therapy.R01AG027237 · NIA · UNIVERSITY OF ROCHESTER · PI Vera Gorbunova · 2006 to 2026
$6.2M
MECHANISMS OF REPLICATIVE SENESCENCE IN CELLSR01AG016694 · NIA · BROWN UNIVERSITY · PI SEDIVY, JOHN M · 1999 to 2024
$5.7M
Control of Gene Expression and Life SpanR01AG024353 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HELFAND, STEPHEN L · 2004 to 2018
$5.5M
Regulation of epigenome stability by SIRT6 during aging. Supplement: Does centenarian variant of SIRT6 or bowhead whale SIRT6 confer protection from Alzheimer's disease?R37AG046320 · NIA · UNIVERSITY OF ROCHESTER · PI Andrei Seluanov · 2019 to 2026
$4.7M
Predoctoral Training in the Molecular Biology of AgingT32AG041688 · NIA · BROWN UNIVERSITY · PI NICOLA NERETTI, John M Sedivy · 2012 to 2026
$3.5M
Effectors of cellular senescence statesR37AG016694 · NIA · BROWN UNIVERSITY · PI SEDIVY, JOHN M · 2009 to 2018
$3.2M
The effect of life span modifying interventions on Alzheimer's Disease in Drosophila and Mice.R01AG067306 · NIA · BROWN UNIVERSITY · PI HELFAND, STEPHEN L · 2020 to 2024
$2.9M
NCI NIH HHS P30 CA014195NCI NIH HHS R21 CA235521NIA NIH HHS K99 AG057812NIA NIH HHS P01 AG047200NIA NIH HHS P01 AG051449NIA NIH HHS R01 AG016694NIA NIH HHS R01 AG024353NIA NIH HHS R01 AG027237NIA NIH HHS R01 AG056306NIA NIH HHS R01 AG057706NIA NIH HHS R01 AG067306NIA NIH HHS R37 AG016694NIA NIH HHS R37 AG046320NIA NIH HHS RF1 AG024353NIA NIH HHS T32 AG041688NIGMS NIH HHS P20 GM119943
6 · The paper itself

Abstract

The genomes of virtually all organisms contain repetitive sequences that are generated by the activity of transposable elements (transposons). Transposons are mobile genetic elements that can move from one genomic location to another; in this process, they amplify and increase their presence in genomes, sometimes to very high copy numbers. In this Review we discuss new evidence and ideas that the activity of retrotransposons, a major subgroup of transposons overall, influences and even promotes the process of ageing and age-related diseases in complex metazoan organisms, including humans. Retrotransposons have been coevolving with their host genomes since the dawn of life. This relationship has been largely competitive, and transposons have earned epithets such as 'junk DNA' and 'molecular parasites'. Much of our knowledge of the evolution of retrotransposons reflects their activity in the germline and is evident from genome sequence data. Recent research has provided a wealth of information on the activity of retrotransposons in somatic tissues during an individual lifespan, the molecular mechanisms that underlie this activity, and the manner in which these processes intersect with our own physiology, health and well-being.

Indexed as

AgingAnimalsDiseaseDNA DamageGene SilencingGenome, HumanGenomicsHumansImmunity, InnateRetroelementsRetroelements

Identifiers

PMID34349292
PMCPMC8600649
OpenAlexW3188425922

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.